Karyopharm taps Amgen, Pfizer veteran as CEO

Oncology-focused Karyopharm Therapeutics has a new CEO and president: Richard Paulson, who brings with him a collective 25 years of leadership experience at Pfizer, Amgen and Ipsen North America.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.